Koga Yuhki, Ohga Shouichi, Nomura Akihiko, Takada Hidetoshi, Hara Toshiro
Department of Pediatrics, Graduate School of Medical Sciences, Kyushu University, 3-1-1 Maidashi Higashi-ku, Fukuoka 812-8582, Japan.
J Pediatr Hematol Oncol. 2006 Jun;28(6):355-61. doi: 10.1097/00043426-200606000-00007.
Diamond-Blackfan anemia (DBA) is a rare congenital pure red cell aplasia occasionally presenting physical anomalies. Ribosomal protein S19 gene (RPS19) is one of the causative genes for DBA; however, the pathologic mechanism of erythroblastopenia and abnormal morphology has not been clarified. To assess the pathophysiology of DBA, the gene expression profile of 2 representative patients carrying no RPS19 mutations was compared with that of aplastic anemia (AA) patients, assessed by the microarray analyses. The K-mean clustering analysis revealed the significant categorization of 28 ribosomal protein (RP) genes into a small set of group (994 genes) (P=2.39E-17), all of which were expressed at lower levels in DBA than in AA patients. RPS19 was categorized into the set of low expressing genes in DBA patients. No mutations were determined in the promoter and coding sequences of top 10 RP genes expressed at the levels over 1.2 of the AA/DBA ratio, in 3 DBA patients. These results indicated that the lower expression of RP gene group, even without the mutation, was a distinctive feature of DBA from AA, although the study number was small. The reduced RP gene expression, by itself, may suggest an underlying mechanism of the constitutional anemia.
先天性纯红细胞再生障碍性贫血(DBA)是一种罕见的先天性纯红细胞再生障碍,偶尔伴有身体异常。核糖体蛋白S19基因(RPS19)是DBA的致病基因之一;然而,成红细胞减少和形态异常的病理机制尚未阐明。为了评估DBA的病理生理学,通过微阵列分析,将2例无RPS19突变的代表性患者的基因表达谱与再生障碍性贫血(AA)患者的基因表达谱进行了比较。K均值聚类分析显示,28个核糖体蛋白(RP)基因显著分类为一小组(994个基因)(P=2.39E-17),所有这些基因在DBA患者中的表达水平均低于AA患者。RPS19被归类为DBA患者中低表达基因组。在3例DBA患者中,未在AA/DBA比值超过1.2的前10个RP基因的启动子和编码序列中检测到突变。这些结果表明,尽管研究数量较少,但RP基因组的低表达,即使没有突变,也是DBA与AA的一个显著特征。RP基因表达降低本身可能提示先天性贫血的潜在机制。